Skip to main navigation Skip to search Skip to main content

RESTORE-1 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm

Project: Research

Project Details

StatusActive
Effective start/end date12/14/22 → 06/30/26

Funding

  • InCarda Therapeutics Incorporated: $29,774.00